Our study elucidates a novel PU.1-mediated transcriptional regulation mechanism governing TREM2 expression, demonstrating its pivotal role in modulating microglial activation dynamics during the progression of Alzheimer’s disease. Here, TREM2 is linked to Alzheimer disease.